Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study

The Lancet

Volumn 351, Issue 9115, 1998, Pages 1535-1539

  Brunetto, M R ^b,f,g   Oliveri, F ^b,f,g   Koehler, M ^b,t   Zahm, F ^b,t   Bonino, F ^f,g   Darvich, J ^c   Findor, J A ^c   Tanno, H ^d   Pinchuk, L ^e   Baldi, M ^f,g   Colombatto, P ^f,g   Colombo, M ^h   Del Ninno, E ^h   Fasani, P ^h   Rumi, M G ^h   Tommasini, M ^h   Alberti, A ⁱ   Benvegnu, L ⁱ   Chemello, L ⁱ   De Salvo, G ⁱ   Awetta, M ^j   Antoniello, S ^j   Pardo, F ^j   Bruno, S ^h   Podda, M ^h   Andreone, P ^k   Bernardi, M ^k   Gasbarrini, G ^k   D'Aquino, M ^l   Tempesta, D ^l   Bottelli, R ^m   Devita, A ⁿ   Masucci, F ⁿ   Belloni, G ^o   Mangia, A ^p   Tappero, G ^q   Caporaso, N ^r   Mazzella, G ^k   Puoti, M ^s   Hoersch, S ^t   Al Traif, I ^u   more..

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b Hospital de Clinicas ^*

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d Hospital Centenario   (Argentina)

^e Sanatorio Municipal J Mendez   (Argentina)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l Ospedale Civile   (Italy)

^m OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁿ S G MOSCATI HOSPITAL   (Italy)

^o FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^p CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^q SAN LUIGI GONZAGA HOSPITAL   (Italy)

^r FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^s SPEDALI CIVILI   (Italy)

^t Pharma Biometric Consulting   (Germany)

^u KING FAHAD MEDICAL CITY   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARGENTINA; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; FEMALE; HUMAN; IRON STORAGE; ITALY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL; PORTAL HYPERTENSION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

EID: 0032560376     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07236-5     Document Type: Article

References (29)

1. 1 Beasley RP. The major aetiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
2. 2 Villa E, Baldini GM, Pasquinelli C, et al. Risk factors for hepatocellular carcinoma in Italy: male sex, hepatitis B virus, non-A, non-B infection and alcohol. Cancer 1988; 62: 611-15.
3. 3 Colombo M, Choo QL, Del Ninno E, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii: 1006-08.
4. 4 Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-75.
5. 5 Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675-80.
6. 6 Caporaso N, Romano M, Marmo R, et al. Hepatitis C virus is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991; 12: 367-71.
7. 7 Stroffolini T, Chiaramonte M, Tiribelli C, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk from a case-control study in Italy. J Hepatol 1992; 16: 360-63.
8. 8 Simonetti RG, Camma C, Fiorello F, et al. Hepatitis C virus infection as a risk for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992; 116: 97-102.
9. 9 Tsukuma H, Huyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
10. 10 Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
11. 11 De Bac C, Stroffolini T, Gaeta GB, et al. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994; 20: 1225-30.
12. 12 Takano S, Yokosuka O, Imazeki F, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 650-55.
13. 13 Trevisani F, D'Intino PE, Caraceni P, et al. Aetiologic factors and clinical presentation of hepatocellular carcinoma. Cancer 1995; 75: 2220-32.
14. 14 Brunetto MR, Oliveri F, Colombatto P, et al. Hepatocellular carcinoma and multiple hepatitis virus infections. In: Kobayashi K, Purcell RH, Simotohao K, Tabor E, eds. Hepatitis C virus and its involvement in the development of HCC. Princeton: Princeton Scientific Publishing, 1994: 61-67.
15. 15 Fausto N, Shank PR. Oncogene expression in liver regeneration and hepatocarcinogenesis. Hepatology 1983; 3: 1010-16.
16. 16 Kekulè AS, Lauer U, Meyer M, et al. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457-61.
17. 17 Wang J, Chenivesse X, Henglein B, et al. Hepatitis B virus integration in a cyclin: a gene in a hepatocellular carcinoma. Nature 1990; 343: 555-57.
18. 18 Ray RB, Lagging LM, Meyer K, et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995; 37: 209-20.
19. 19 Kaklamani E, Trichopoulos D, Tzonous A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 1974-76.
20. 20 NIH Consensus Development Conference: management of hepatitis C. Hepatology 1997; 26: 83-108.
21. 21 Nishiguchi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-55.
22. 22 Mazzella G, Accogli E, Sottili S, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996; 24: 141-47.
23. 23 Koretz RL. Interferon and hepatocellular carcinoma. Lancet 1996; 347: 194.
24. 24 Andreone P, Cursaro C, Gramenzi A, et al. Interferon and hepatocellular carcinoma. Lancet 1996; 347: 195.
25. 25 Harper SE, Dienstag JL. Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis? Hepatology 1996; 23: 930-33.
26. 26 Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5: 431-35.
27. 27 Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-99.
28. 28 Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease: effects of interferon alfa therapy. N Engl J Med 1991; 324: 933-40.
29. 29 Ryff JC. Usefulness of interferon for treatment of hepatitis C. J Hepatol 1995; 22: 101-09.